Related Experiment Video
Updated: Feb 12, 2026

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Published on: January 20, 2023
Biopolymer-stabilized zein nanoparticles for pressure ulcer management: Formulation, optimization, and preliminary in
Yasmin E Emara1, Wessam M El-Refaie2, Maram M Allam3
1Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 2152, Egypt.
Abstract:
Pressure ulcers (PUs) remain a major healthcare burden, requiring innovative, safe, and effective therapies. Bioactive polysaccharide-based nanoplatforms offer promise owing to their biocompatibility, biodegradability, and wound-healing potential. This study aimed to develop and optimize zein nanoparticles (ZnNPs) stabilized with natural bioactive polysaccharides-Tragacanth (TG), Dextran sodium sulphate (Dx), Pectin (Pec), or Acacia (Ac)-for PU management. Formulations were optimized by varying Zn: biopolymer ratio, order of mixing, and polymer type, then characterized by colloidal properties, TEM, and stability testing. To assess additive therapeutic effects, Naringenin (NAR) was incorporated into ZnTGNPs. All optimized systems were further evaluated in vivo in a PU rat model through wound contraction and histopathology. Results revealed that TG-stabilized ZnNPs (Zn TG NPs) exhibited superior characteristics (167± 1.5 nm, 0.25± 0.06 & -33 mV) and significant three-month stability. The incorporation of NAR into Zn TG NPs resulted in 98% encapsulation efficiency and controlled release over 48 h. In vivo evaluation demonstrated that both drug-free and NAR-loaded Zn TG NPs promoted significant wound closure and histological regeneration compared with controls. Interestingly, drug-free Zn TG NPs achieved healing efficacy comparable to their drug-loaded counterparts, underscoring the intrinsic bioactivity of TG in supporting tissue repair. These findings support the potential of biopolymer-based nanoplatforms as effective, drug-free treatments for pressure ulcers, offering a safe and sustainable alternative to conventional medicated therapies. Further long-term and mechanistic studies are warranted to confirm their translational potential in clinical wound care.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Assessing Blood pressure in the Leg
Preparation:
Mitral Valve Prolapse II: Assessment and Management
Nuclear Stability
To hold positively charged protons together...
RNA Stability

